They demonstrated that CD8+ T cells and M1/M2 macrophage ratios were elevated in neu-deletion murine breast tumors following local injection with R848-TSLs, combined with systemic anti-PD-1 and local hyperthermia, compared with anti-PD-1 or no-treatment controls. The gene discussed is PDCD1; the disease is breast neoplasm.